Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.
Hematology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Obstetrics and Gynecology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada. Electronic address: mrodger@ohri.ca.
Marc A
MA
Rodger
Hematology, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Penny
P
Phillips
Department of Medicine, McGill University, Canada; Department of Obstetrics & Gynecology, McGill University, Canada.
Susan R
SR
Kahn
McMaster University, Hamilton, Ontario, Canada.
Shannon
S
Bates
McMaster University, Hamilton, Ontario, Canada.
Sarah
S
McDonald
University of Alberta, Edmonton, Alberta, Canada.
Rshmi
R
Khurana
Department of Obstetrics and Gynecology, University of Virginia, United States.
Andra H
AH
James
Division of Hematology, University of Washington, United States; Puget Sound Blood Center, United States.
Barbara A
BA
Konkle
D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D010865:Pilot Projects; D049590:Postpartum Period / Q000187:drug effects; D054556:Venous Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight
Low molecular weight heparin; Postpartum; Randomized controlled trial; Thromboprophylaxis; Venous thromboembolism